Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study

MLA

Won Young Lee, et al. “Impact of Polymyxin B Hemoperfusion Therapy on High Endotoxin Activity Level Patients after Successful Infection Source Control: A Prospective Cohort Study.” Scientific Reports, vol. 11, Dec. 2021. EBSCOhost, https://doi.org/10.1038/s41598-021-03055-8.

APA

Won Young Lee, Hee Ju Kim, & Eun Young Kim. (2021). Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study. Scientific Reports, 11. https://doi.org/10.1038/s41598-021-03055-8

Chicago

Won Young Lee, Hee Ju Kim, and Eun Young Kim. 2021. “Impact of Polymyxin B Hemoperfusion Therapy on High Endotoxin Activity Level Patients after Successful Infection Source Control: A Prospective Cohort Study.” Scientific Reports 11 (December). doi:10.1038/s41598-021-03055-8.